Welcome
Fresenius Kabi is the leader in infusion therapy and clinical nutrition in Europe and in its most important countries of Latin America and Asia Pacific. Within I.V. generic drugs, Fresenius Kabi counts among the leading suppliers in the U.S. market.
All over the world more than 24,000 employees are committed to improving the quality of life of critically and chronically ill patients with innovative products for patients in hospitals and outpatients.
|
| NEWS | CONGRESSES |
|---|---|
May 03, 2012Excellent start into 2012 – Fresenius raises outlook PDF-Download (153 KBytes) 
March 09, 2012 Fresenius Announces Management Board Changes PDF-Download (25 KBytes)
February 21, 2012 Fresenius achieves record sales and earnings in 2011 – Strong growth expected in all business segments for 2012 PDF-Download (189 KBytes)
|
ERA/EDTA May 24 - 27, 2012 Paris, France You are more than welcome to visit our booth at ERA/EDTA Link to congress websiteEuroanaesthesia June 09 - 12, 2012 Paris, France Come and visit us on our Fresenius Kabi booth at Euroanaesthesia Link to congress website Fresenius Kabi Symposia InformationICRNM June 26 - 30, 2012 Honolulu, Hawaii We are looking forward to welcome you on our booth at ICRNM Link to congress website |
| Overview News |
Overview Congresses |